ก าหนดไว้ในประกาศว่าด้วยการยื่นแบบแสดงรายการข้อมูลการเสนอขายตราสารหนี้ ส าหรับความคืบหน้าของโครงการ ให้รายงานตามช่องทางที่เปิดเผยไว้ในข้อ 2.4 3. External Review Provider ส านักงานสนับสนุนให้ issuer
accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor
additional information, both before and after the offering, in accordance with the relevant sustainability standards. Additionally, a review on sustainability-related matter by a qualified external review
advisers under the “ACMF Pass” initiative launched in 2018, allowing ASEAN investors greater access to professional services.A revised MoU on the Streamlined Review Framework for ASEAN Common
effective. In the first quarter of the fiscal year 2019, according to an actuary hired by the company to review the calculation of employee accrued benefits, and the Labor Protection Act (No. 7), B.E.2562
of the fiscal year 2019, according to an actuary hired by the company to review the calculation of employee accrued benefits, and the Labor Protection Act (No.7), B.E.2562 (2019) issued in the
review of consolidated interim financial statements of the Group and the interim financial statement of the Company for the period ending March 31, 2018. The results shows net profit of Baht 195.22 million
Company Limited would like to report the company’s operating results and submit the auditor’s report on review of interim financial information for the third quarter ended September 30, 2018 as follows: The
, according to an actuary hired by the company to review the calculation of employee accrued benefits, and the Labor Protection Act (No.7), B.E.2562 (2019) issued in the Government Gazette on April 5, 2019 on